Lpoxy Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 30, 2027The maintenance fee for Enteric Aerobization Therapy (US 11,883,428) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Oct 2, 2027The maintenance fee for Treatment of Inflammatory Bowel Diseases Through Administration of Enteric Aerobization Therapy (US 11,944,641) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
- 1 fee due Nov 7, 2027The maintenance fee for Methods for inhibiting anaerobic microorganisms (US 11,975,023) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,945,974 | Methods and compositions to modulate the gut microbiota and to manage weight In force · From the USPTO record | In force | From the USPTO record | |
| US 11,179,356 | Methods and compositions to modulate the gut microbiota and to manage weight In force · From the USPTO record | In force | From the USPTO record | |
| US 11,179,357 | Methods and compositions to modulate the gut microbiota and to manage weight In force · From the USPTO record | In force | From the USPTO record | |
| US 11,311,573 | Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota In force · From the USPTO record | In force | From the USPTO record | |
| US 11,883,428 | Enteric Aerobization Therapy In force · High confidence | In force | High confidence | |
| US 11,944,641 | Treatment of Inflammatory Bowel Diseases Through Administration of Enteric Aerobization Therapy In force · High confidence | In force | High confidence | |
| US 11,975,023 | Methods for inhibiting anaerobic microorganisms In force · From the USPTO record | In force | From the USPTO record | |
| US 12,036,239 | Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 12,053,488 | Compositions for Inhibiting Anaerobic Microorganisms In force · High confidence | In force | High confidence | |
| US 12,109,244 | Enteric Aerobization Therapy In force · Low confidence | In force | Low confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending